Oral therapy IFB-088 (icerguastat) was safe and significantly slowed disease progression in certain people with amyotrophic ... studies and pave the way for new treatment possibilities for ALS,” he ...

Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.

causing progressive muscular weakness of the limbs (limb onset) or dysarthria and dysphagia (bulbar onset). The average life expectancy is 3 years from the onset of symptoms, and patients usually die ...

Fat molecules called polyunsaturated fatty acids, or PUFAs, can help lessen nerve damage in amyotrophic lateral sclerosis (ALS), according to a study of fruit flies and cell models. Previous studies ...

The development of these skills correlates with progressive evolution of a direct corticomotoneuronal system that is unique to primates and markedly enhanced in humans. The failure of this system in ...

Motor neuron diseases are a group of fatal progressive disorders that rob the body and brain of the ability to function.

These results imply the analysis of T1-relaxation times as a promising diagnostic tool that can distinguish ALS patients from the control group. Ongoing longitudinal studies may provide deeper ...

A joint model of the ALS Functional Rating Scale–Revised and survival was used to measure the primary efficacy outcome, which was the change in disease severity from baseline through week 24. The ...